PB: "London" - OpacWWW - Prolib Integro

Skocz do pozycji: 1.

Tytuł:: Correction: Patient-controlled analgesia morphine for the management of acute pain in the emergency department: a systematic review and meta-analysis.
Autorzy:: Oon MB; Department of Emergency Medicine, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kota Bharu, Kelantan, Malaysia.
Hisamuddin NNAR; Department of Emergency Medicine, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kota Bharu, Kelantan, Malaysia. .; Hospital Universiti Sains Malaysia, Kubang Kerian, Kota Bharu, Kelantan, Malaysia. .
Noor NM; Department of Family Medicine, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kota Bharu, Kelantan, Malaysia.
Yazid MB; Department of Emergency Medicine, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kota Bharu, Kelantan, Malaysia.; Pokaż więcej
Źródło:: International journal of emergency medicine [Int J Emerg Med] 2024 Apr 10; Vol. 17 (1), pp. 54. Date of Electronic Publication: 2024 Apr 10.
Typ publikacji:: Published Erratum

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Targeting transitioning lung monocytes/macrophages as treatment strategies in lung disease related to environmental exposures.
Autorzy:: Schwab AD; Division of Allergy & Immunology, University of Nebraska Medical Center, Omaha, NE, USA.
Wyatt TA; Veterans Affairs Nebraska-Western Iowa Health Care System, Research Service, Omaha, NE, USA.; Division of Pulmonary, Critical Care & Sleep, University of Nebraska Medical Center, Omaha, NE, USA.; Department of Environmental, Agricultural and Occupational Health, College of Public Health, University of Nebraska Medical Center, Omaha, NE, USA.
Moravec G; Division of Allergy & Immunology, University of Nebraska Medical Center, Omaha, NE, USA.
Thiele GM; Veterans Affairs Nebraska-Western Iowa Health Care System, Research Service, Omaha, NE, USA.; Division of Rheumatology and Immunology, Department of Internal Medicine, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Nelson AJ; Division of Allergy & Immunology, University of Nebraska Medical Center, Omaha, NE, USA.
Gleason A; Division of Allergy & Immunology, University of Nebraska Medical Center, Omaha, NE, USA.
Schanze O; Division of Allergy & Immunology, University of Nebraska Medical Center, Omaha, NE, USA.
Duryee MJ; Veterans Affairs Nebraska-Western Iowa Health Care System, Research Service, Omaha, NE, USA.; Division of Rheumatology and Immunology, Department of Internal Medicine, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Romberger DJ; Veterans Affairs Nebraska-Western Iowa Health Care System, Research Service, Omaha, NE, USA.; Division of Pulmonary, Critical Care & Sleep, University of Nebraska Medical Center, Omaha, NE, USA.
Mikuls TR; Veterans Affairs Nebraska-Western Iowa Health Care System, Research Service, Omaha, NE, USA.; Division of Rheumatology and Immunology, Department of Internal Medicine, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Poole JA; Division of Allergy & Immunology, University of Nebraska Medical Center, Omaha, NE, USA. .; Pokaż więcej
Źródło:: Respiratory research [Respir Res] 2024 Apr 09; Vol. 25 (1), pp. 157. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:: Journal Article
MeSH Terms:: Monocytes*/metabolism
Lung Diseases*/metabolism
Mice ; Animals ; Liposomes/metabolism ; Vimentin/metabolism ; Lipopolysaccharides/pharmacology ; Clodronic Acid/pharmacology ; Clodronic Acid/metabolism ; CD8-Positive T-Lymphocytes ; Lung ; Macrophages/metabolism ; Environmental Exposure ; Collagen/metabolism ; Mice, Inbred C57BL

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: GLUT3-mediated cigarette smoke-induced epithelial-mesenchymal transition in chronic obstructive pulmonary disease through the NF-kB/ZEB1 pathway.
Autorzy:: Ding Y; Department of Respiratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, Wuxi, Jiangsu, 214023, People's Republic of China.
Wang Z; Department of Respiratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, Wuxi, Jiangsu, 214023, People's Republic of China.
Zhang Z; Department of Respiratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, Wuxi, Jiangsu, 214023, People's Republic of China.
You R; Department of Respiratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, Wuxi, Jiangsu, 214023, People's Republic of China.
Wu Y; Department of Respiratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, Wuxi, Jiangsu, 214023, People's Republic of China. .
Bian T; Department of Respiratory Medicine, Wuxi People's Hospital, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, Wuxi, Jiangsu, 214023, People's Republic of China. .; Pokaż więcej
Źródło:: Respiratory research [Respir Res] 2024 Apr 09; Vol. 25 (1), pp. 158. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:: Journal Article
MeSH Terms:: Cigarette Smoking*/adverse effects
Pulmonary Disease, Chronic Obstructive*/metabolism
Humans ; Mice ; Animals ; NF-kappa B/metabolism ; Airway Remodeling ; Glucose Transporter Type 3/metabolism ; Epithelial-Mesenchymal Transition ; Epithelial Cells/metabolism ; Zinc Finger E-box-Binding Homeobox 1/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Screening for harmful substance use in emergency departments: a systematic review.
Autorzy:: Moe J; Department of Emergency Medicine, University of British Columbia, Diamond Health Care Centre, 11 Floor - 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada. .
Koh J; Department of Emergency Medicine, Queen's University, Kingston Health Sciences Centre, 76 Stuart Street, Kingston, ON, K7L 2V7, Canada.
Ma JA; Department of Emergency Medicine, University of Manitoba, S203 Medical Sciences Building, 750 Bannatyne Avenue, Winnipeg, MB, R3E 0W2, Canada.
Pei LX; Department of Emergency Medicine, University of British Columbia, Diamond Health Care Centre, 11 Floor - 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada.
MacLean E; Department of Emergency Medicine, University of British Columbia, Diamond Health Care Centre, 11 Floor - 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada.
Keech J; School of Medicine, Queen's University, 15 Arch Street, Kingston, ON, K7L 3N6, Canada.
Maguire K; Department of Emergency Medicine, University of British Columbia, Diamond Health Care Centre, 11 Floor - 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada.
Ronsley C; Department of Emergency Medicine, University of British Columbia, Diamond Health Care Centre, 11 Floor - 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada.
Doyle-Waters MM; Centre for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Research Institute, 7th Floor, 828 West 10th Avenue, Research Pavilion, Vancouver, BC, V5Z 1M9, Canada.
Brubacher JR; Department of Emergency Medicine, University of British Columbia, Diamond Health Care Centre, 11 Floor - 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada.; Pokaż więcej
Źródło:: International journal of emergency medicine [Int J Emerg Med] 2024 Apr 08; Vol. 17 (1), pp. 52. Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Comprehensive machine learning boosts structure-based virtual screening for PARP1 inhibitors.
Autorzy:: Caba K; Department of Bioengineering, Imperial College London, London, SW7 2AZ, UK.
Tran-Nguyen VK; Unité de Biologie Fonctionnelle et Adaptative (BFA), UFR Sciences du Vivant, Université Paris Cité, 75013, Paris, France.
Rahman T; Department of Pharmacology, University of Cambridge, Cambridge, CB2 1PD, UK.
Ballester PJ; Department of Bioengineering, Imperial College London, London, SW7 2AZ, UK. .; Pokaż więcej
Źródło:: Journal of cheminformatics [J Cheminform] 2024 Apr 07; Vol. 16 (1), pp. 40. Date of Electronic Publication: 2024 Apr 07.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Emergency department responses to nursing shortages.
Autorzy:: Hodgson NR; Department of Emergency Medicine, Mayo Clinic Arizona, 5777 E Mayo Blvd, Phoenix, AZ, 85054, USA. .
Kwun R; Department of Emergency Medicine, Swedish Medical Center, Issaquah, WA, USA.
Gorbatkin C; Department of Emergency Medicine, Madigan Army Medical Center, JBLM, Lakewood, WA, USA.
Davies J; American College of Emergency Physicians, Irving, TX, USA.
Fisher J; American College of Emergency Physicians, Irving, TX, USA.; Pokaż więcej
Corporate Authors:: ACEP Emergency Medicine Practice Committee
Źródło:: International journal of emergency medicine [Int J Emerg Med] 2024 Apr 05; Vol. 17 (1), pp. 51. Date of Electronic Publication: 2024 Apr 05.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Carbon sequestration potential of plantation forests in New Zealand - no single tree species is universally best.
Autorzy:: Salekin S; Scion Research Ltd. (New Zealand Forest Research Institute), Rotorua, 3046, New Zealand. .
Dickinson YL; Scion Research Ltd. (New Zealand Forest Research Institute), Rotorua, 3046, New Zealand.
Bloomberg M; New Zealand School of Forestry, University of Canterbury, Christchurch, 8041, New Zealand.
Meason DF; Scion Research Ltd. (New Zealand Forest Research Institute), Rotorua, 3046, New Zealand.; Pokaż więcej
Źródło:: Carbon balance and management [Carbon Balance Manag] 2024 Apr 05; Vol. 19 (1), pp. 11. Date of Electronic Publication: 2024 Apr 05.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Using test-time augmentation to investigate explainable AI: inconsistencies between method, model and human intuition.
Autorzy:: Hartog PBR; Molecular AI, Discovery Sciences, R &D, AstraZeneca, 431 83, Mölndal, Sweden. .; Institute of Structural Biology, Helmholtz Munich, Munich, 85764, Germany. .
Krüger F; Institute of Structural Biology, Helmholtz Munich, Munich, 85764, Germany.
Genheden S; Molecular AI, Discovery Sciences, R &D, AstraZeneca, 431 83, Mölndal, Sweden.
Tetko IV; Institute of Structural Biology, Helmholtz Munich, Munich, 85764, Germany.; Pokaż więcej
Źródło:: Journal of cheminformatics [J Cheminform] 2024 Apr 04; Vol. 16 (1), pp. 39. Date of Electronic Publication: 2024 Apr 04.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Bibliometric analysis of ChatGPT in medicine.
Autorzy:: Gande S; Academy of the Lakes, Land O' Lakes, FL, USA.
Gould M; Rollins College, Winter Park, FL, USA.
Ganti L; University of Central Florida, Orlando, FL, USA. .; Warren Alpert Medical School of Brown University, RI Providence, USA. .; Pokaż więcej
Źródło:: International journal of emergency medicine [Int J Emerg Med] 2024 Apr 04; Vol. 17 (1), pp. 50. Date of Electronic Publication: 2024 Apr 04.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Updated reference values for static lung volumes from a healthy population in Austria.
Autorzy:: Mraz T; Department of Respiratory and Pulmonary Diseases, Vienna Healthcare Group, Clinic Penzing, Sanatoriumstrasse 2, Vienna, 1140, Austria. .; Ludwig Boltzmann Institute for Lung Health, Vienna, Austria. .
Asgari S; Ludwig Boltzmann Institute for Lung Health, Vienna, Austria.; Faculty of Medicine, Sigmund Freud Private University, Vienna, Austria.
Karimi A; Ludwig Boltzmann Institute for Lung Health, Vienna, Austria.; Faculty of Medicine, Sigmund Freud Private University, Vienna, Austria.
Breyer MK; Department of Respiratory and Pulmonary Diseases, Vienna Healthcare Group, Clinic Penzing, Sanatoriumstrasse 2, Vienna, 1140, Austria.; Ludwig Boltzmann Institute for Lung Health, Vienna, Austria.
Hartl S; Ludwig Boltzmann Institute for Lung Health, Vienna, Austria.; Faculty of Medicine, Sigmund Freud Private University, Vienna, Austria.
Sunanta O; Ludwig Boltzmann Institute for Lung Health, Vienna, Austria.
Ofenheimer A; Ludwig Boltzmann Institute for Lung Health, Vienna, Austria.; Faculty of Medicine, Sigmund Freud Private University, Vienna, Austria.; School of Nutrition and Translational Research in Metabolism, NUTRIM, Maastricht University Medical Center, Maastricht, the Netherlands.
Burghuber OC; Department of Respiratory and Pulmonary Diseases, Vienna Healthcare Group, Clinic Penzing, Sanatoriumstrasse 2, Vienna, 1140, Austria.; Ludwig Boltzmann Institute for Lung Health, Vienna, Austria.; Faculty of Medicine, Sigmund Freud Private University, Vienna, Austria.
Zacharasiewicz A; Department of Pediatrics, Clinic Ottakring, Vienna, Austria.
Lamprecht B; Department of Pulmonology, Kepler University Hospital, Linz, Austria.; Medical Faculty, Johannes Kepler University, Linz, Austria.
Schiffers C; Ludwig Boltzmann Institute for Lung Health, Vienna, Austria.
Wouters EFM; Ludwig Boltzmann Institute for Lung Health, Vienna, Austria.; Faculty of Medicine, Sigmund Freud Private University, Vienna, Austria.; School of Nutrition and Translational Research in Metabolism, NUTRIM, Maastricht University Medical Center, Maastricht, the Netherlands.
Breyer-Kohansal R; Ludwig Boltzmann Institute for Lung Health, Vienna, Austria.; Department of Respiratory and Pulmonary Diseases, Vienna Healthcare Group, Clinic Hietzing, Vienna, Austria.; Pokaż więcej
Źródło:: Respiratory research [Respir Res] 2024 Apr 03; Vol. 25 (1), pp. 155. Date of Electronic Publication: 2024 Apr 03.
Typ publikacji:: Journal Article
MeSH Terms:: Lung*
Male ; Adult ; Child ; Female ; Humans ; Austria/epidemiology ; Reference Values ; Lung Volume Measurements/methods ; Total Lung Capacity ; Spirometry/methods ; Forced Expiratory Volume ; Vital Capacity

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Clinical significance of elevated D-dimer in emergency department patients: a retrospective single-center analysis.
Autorzy:: Alshalhoub M; Emergency Medicine Department, Ministry of the National Guard - Health Affairs, Riyadh, Saudi Arabia. .; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia. .
Alhusain F; Emergency Medicine Department, Ministry of the National Guard - Health Affairs, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Alsulaiman F; Emergency Medicine Department, Ministry of the National Guard - Health Affairs, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Alturki A; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Aldayel S; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Alsalamah M; Emergency Medicine Department, Ministry of the National Guard - Health Affairs, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.; Pokaż więcej
Źródło:: International journal of emergency medicine [Int J Emerg Med] 2024 Apr 03; Vol. 17 (1), pp. 47. Date of Electronic Publication: 2024 Apr 03.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: The state of emergency medicine in Greece: at critical momentum.
Autorzy:: Tsiftsis D; Emergency Department, Nikaia General Hospital, D. Mantouvalou 3, Nikaia, 18454, Greece. .
Ulrich A; Department of Emergency Medicine, Yale University School of Medicine, 464 Congress Avenue, Suite 260, New Haven, CT, USA.
Notas G; University of Crete School of Medicine and University Hospital of Heraklion, 13 Andrea Kalokairinou Str., Heraklion, 71500, Greece.
Patrikakou A; 2nd Regional Health Authority of Piraeus and the Aegean, Thivon 196, Agios Ioannis Rentis, 18233, Greece.
Reid E; Department of Emergency Medicine, Yale University School of Medicine, 464 Congress Avenue, Suite 260, New Haven, CT, USA.; Pokaż więcej
Źródło:: International journal of emergency medicine [Int J Emerg Med] 2024 Apr 03; Vol. 17 (1), pp. 46. Date of Electronic Publication: 2024 Apr 03.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: NR2F2 alleviates pulmonary fibrosis by inhibition of epithelial cell senescence.
Autorzy:: Wan R; State Key Laboratory Cell Differentiation and Regulation, Henan International Joint Laboratory of Pulmonary Fibrosis, Henan center for outstanding overseas scientists of pulmonary fibrosis, College of Life Science, Institute of Biomedical Science, Pingyuan Laboratory, Henan Normal University, Xinxiang, 453007, Henan, China.
Long S; State Key Laboratory Cell Differentiation and Regulation, Henan International Joint Laboratory of Pulmonary Fibrosis, Henan center for outstanding overseas scientists of pulmonary fibrosis, College of Life Science, Institute of Biomedical Science, Pingyuan Laboratory, Henan Normal University, Xinxiang, 453007, Henan, China.
Ma S; State Key Laboratory Cell Differentiation and Regulation, Henan International Joint Laboratory of Pulmonary Fibrosis, Henan center for outstanding overseas scientists of pulmonary fibrosis, College of Life Science, Institute of Biomedical Science, Pingyuan Laboratory, Henan Normal University, Xinxiang, 453007, Henan, China.
Yan P; State Key Laboratory Cell Differentiation and Regulation, Henan International Joint Laboratory of Pulmonary Fibrosis, Henan center for outstanding overseas scientists of pulmonary fibrosis, College of Life Science, Institute of Biomedical Science, Pingyuan Laboratory, Henan Normal University, Xinxiang, 453007, Henan, China.
Li Z; State Key Laboratory Cell Differentiation and Regulation, Henan International Joint Laboratory of Pulmonary Fibrosis, Henan center for outstanding overseas scientists of pulmonary fibrosis, College of Life Science, Institute of Biomedical Science, Pingyuan Laboratory, Henan Normal University, Xinxiang, 453007, Henan, China.
Xu K; State Key Laboratory Cell Differentiation and Regulation, Henan International Joint Laboratory of Pulmonary Fibrosis, Henan center for outstanding overseas scientists of pulmonary fibrosis, College of Life Science, Institute of Biomedical Science, Pingyuan Laboratory, Henan Normal University, Xinxiang, 453007, Henan, China.
Lian H; State Key Laboratory Cell Differentiation and Regulation, Henan International Joint Laboratory of Pulmonary Fibrosis, Henan center for outstanding overseas scientists of pulmonary fibrosis, College of Life Science, Institute of Biomedical Science, Pingyuan Laboratory, Henan Normal University, Xinxiang, 453007, Henan, China.
Li W; State Key Laboratory Cell Differentiation and Regulation, Henan International Joint Laboratory of Pulmonary Fibrosis, Henan center for outstanding overseas scientists of pulmonary fibrosis, College of Life Science, Institute of Biomedical Science, Pingyuan Laboratory, Henan Normal University, Xinxiang, 453007, Henan, China.
Duan Y; State Key Laboratory Cell Differentiation and Regulation, Henan International Joint Laboratory of Pulmonary Fibrosis, Henan center for outstanding overseas scientists of pulmonary fibrosis, College of Life Science, Institute of Biomedical Science, Pingyuan Laboratory, Henan Normal University, Xinxiang, 453007, Henan, China.
Zhu M; State Key Laboratory Cell Differentiation and Regulation, Henan International Joint Laboratory of Pulmonary Fibrosis, Henan center for outstanding overseas scientists of pulmonary fibrosis, College of Life Science, Institute of Biomedical Science, Pingyuan Laboratory, Henan Normal University, Xinxiang, 453007, Henan, China.
Wang L; State Key Laboratory Cell Differentiation and Regulation, Henan International Joint Laboratory of Pulmonary Fibrosis, Henan center for outstanding overseas scientists of pulmonary fibrosis, College of Life Science, Institute of Biomedical Science, Pingyuan Laboratory, Henan Normal University, Xinxiang, 453007, Henan, China. .; College of Life Science, Henan Normal University, Xinxiang, Henan, China. .
Yu G; State Key Laboratory Cell Differentiation and Regulation, Henan International Joint Laboratory of Pulmonary Fibrosis, Henan center for outstanding overseas scientists of pulmonary fibrosis, College of Life Science, Institute of Biomedical Science, Pingyuan Laboratory, Henan Normal University, Xinxiang, 453007, Henan, China. .; College of Life Science, Henan Normal University, Xinxiang, Henan, China. .; Pokaż więcej
Źródło:: Respiratory research [Respir Res] 2024 Apr 02; Vol. 25 (1), pp. 154. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:: Journal Article
MeSH Terms:: Cellular Senescence*
Idiopathic Pulmonary Fibrosis*/drug therapy
Animals ; Mice ; Bleomycin/adverse effects ; Epithelial Cells/metabolism ; Lung/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: A WNT mimetic with broad spectrum FZD-specificity decreases fibrosis and improves function in a pulmonary damage model.
Autorzy:: Patel M; Surrozen, Inc., 171 Oyster Point Blvd, Suite 400, South San Francisco, CA, 94080, USA.
Post Y; Surrozen, Inc., 171 Oyster Point Blvd, Suite 400, South San Francisco, CA, 94080, USA.
Hill N; Surrozen, Inc., 171 Oyster Point Blvd, Suite 400, South San Francisco, CA, 94080, USA.
Sura A; Surrozen, Inc., 171 Oyster Point Blvd, Suite 400, South San Francisco, CA, 94080, USA.
Ye J; Surrozen, Inc., 171 Oyster Point Blvd, Suite 400, South San Francisco, CA, 94080, USA.
Fisher T; Surrozen, Inc., 171 Oyster Point Blvd, Suite 400, South San Francisco, CA, 94080, USA.
Suen N; Surrozen, Inc., 171 Oyster Point Blvd, Suite 400, South San Francisco, CA, 94080, USA.
Zhang M; Surrozen, Inc., 171 Oyster Point Blvd, Suite 400, South San Francisco, CA, 94080, USA.
Cheng L; Surrozen, Inc., 171 Oyster Point Blvd, Suite 400, South San Francisco, CA, 94080, USA.
Pribluda A; Surrozen, Inc., 171 Oyster Point Blvd, Suite 400, South San Francisco, CA, 94080, USA.
Chen H; Surrozen, Inc., 171 Oyster Point Blvd, Suite 400, South San Francisco, CA, 94080, USA.
Yeh WC; Surrozen, Inc., 171 Oyster Point Blvd, Suite 400, South San Francisco, CA, 94080, USA.
Li Y; Surrozen, Inc., 171 Oyster Point Blvd, Suite 400, South San Francisco, CA, 94080, USA.
Baribault H; Surrozen, Inc., 171 Oyster Point Blvd, Suite 400, South San Francisco, CA, 94080, USA.
Fletcher RB; Surrozen, Inc., 171 Oyster Point Blvd, Suite 400, South San Francisco, CA, 94080, USA. .; Pokaż więcej
Źródło:: Respiratory research [Respir Res] 2024 Apr 02; Vol. 25 (1), pp. 153. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:: Journal Article
MeSH Terms:: beta Catenin*/metabolism
Idiopathic Pulmonary Fibrosis*/chemically induced
Idiopathic Pulmonary Fibrosis*/drug therapy
Idiopathic Pulmonary Fibrosis*/metabolism
Adult ; Animals ; Humans ; Lung/metabolism ; Wnt Signaling Pathway ; Bleomycin/toxicity

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: An AI-based multiphase framework for improving the mechanical ventilation availability in emergency departments during respiratory disease seasons: a case study.
Autorzy:: Ortiz-Barrios M; Centro de Investigación en Gestión e Ingeniería de Producción (CIGIP), Universitat Politecnica de Valencia, Camino de Vera, s/n, Valencia, 46022, Spain. .; Department of Productivity and Innovation, Universidad de la Costa CUC, Barranquilla, 080002, Colombia. .
Petrillo A; Department of Engineering, University of Naples 'Parthenope', Naples, Italy.
Arias-Fonseca S; Department of Productivity and Innovation, Universidad de la Costa CUC, Barranquilla, 080002, Colombia.
McClean S; School of Computing, Ulster University, Belfast, BT15 1ED, UK.
de Felice F; Department of Engineering, University of Naples 'Parthenope', Naples, Italy.
Nugent C; School of Computing, Ulster University, Belfast, BT15 1ED, UK.
Uribe-López SA; Academic Multidisciplinary Division of Jalpa de Mendez, Juarez Autonomous University of Tabasco, Jalpa de Mendez, Tabasco, Mexico.; Pokaż więcej
Źródło:: International journal of emergency medicine [Int J Emerg Med] 2024 Apr 02; Vol. 17 (1), pp. 45. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Hats off to 20S proteasome substrate discovery.
Autorzy:: Church TR; Department of Biological Chemistry, The Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
Brennan A; Department of Biological Chemistry, The Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
Margolis SS; Department of Biological Chemistry, The Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. .; Solomon H. Snyder Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. .; Pokaż więcej
Źródło:: Molecular systems biology [Mol Syst Biol] 2024 Apr; Vol. 20 (4), pp. 293-295. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:: Journal Article
MeSH Terms:: Proteasome Endopeptidase Complex*
Cytoplasm

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor.
Autorzy:: Trepte P; Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany. .; Brain Development and Disease, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, 1030, Vienna, Austria. .
Secker C; Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany. .; Zuse Institute Berlin, Berlin, Germany. .
Olivet J; Laboratory of Viral Interactomes, Interdisciplinary Cluster for Applied Genoproteomics (GIGA)-Molecular Biology of Diseases, University of Liège, 4000, Liège, Belgium.; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Structural Biology Unit, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation, Katholieke Universiteit Leuven, 3000, Leuven, Belgium.
Blavier J; Laboratory of Viral Interactomes, Interdisciplinary Cluster for Applied Genoproteomics (GIGA)-Molecular Biology of Diseases, University of Liège, 4000, Liège, Belgium.
Kostova S; Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany.
Maseko SB; Laboratory of Viral Interactomes, Interdisciplinary Cluster for Applied Genoproteomics (GIGA)-Molecular Biology of Diseases, University of Liège, 4000, Liège, Belgium.
Minia I; RNA Biology and Posttranscriptional Regulation, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin Institute for Medical Systems Biology, 13125, Berlin, Germany.
Silva Ramos E; Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany.
Cassonnet P; Département de Virologie, Unité de Génétique Moléculaire des Virus à ARN (GMVR), Institut Pasteur, Centre National de la Recherche Scientifique (CNRS), Université de Paris, Paris, France.
Golusik S; Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany.
Zenkner M; Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany.
Beetz S; Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany.
Liebich MJ; Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany.
Scharek N; Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany.
Schütz A; Protein Production & Characterization, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany.
Sperling M; Multifunctional Colloids and Coating, Fraunhofer Institute for Applied Polymer Research (IAP), 14476, Potsdam-Golm, Germany.
Lisurek M; Structural Chemistry and Computational Biophysics, Leibniz-Institut für Molekulare Pharmakologie (FMP), 13125, Berlin, Germany.
Wang Y; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Spirohn K; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Hao T; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Calderwood MA; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Hill DE; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Landthaler M; RNA Biology and Posttranscriptional Regulation, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin Institute for Medical Systems Biology, 13125, Berlin, Germany.; Institute of Biology, Humboldt-Universität zu Berlin, 13125, Berlin, Germany.
Choi SG; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA. .; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA. .; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. .
Twizere JC; Laboratory of Viral Interactomes, Interdisciplinary Cluster for Applied Genoproteomics (GIGA)-Molecular Biology of Diseases, University of Liège, 4000, Liège, Belgium. .; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA. .; TERRA Teaching and Research Center, Gembloux Agro-Bio Tech, University of Liège, 5030, Gembloux, Belgium. .; Laboratory of Algal Synthetic and Systems Biology, Division of Science and Math, New York University Abu Dhabi, Abu Dhabi, UAE. .
Vidal M; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA. marc_.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA. marc_.
Wanker EE; Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany. .; Pokaż więcej
Źródło:: Molecular systems biology [Mol Syst Biol] 2024 Apr; Vol. 20 (4), pp. 428-457. Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:: Journal Article
MeSH Terms:: SARS-CoV-2*/metabolism
COVID-19*
Humans ; Methyltransferases/metabolism ; Artificial Intelligence ; Drug Discovery

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Integrated annotation prioritizes metabolites with bioactivity in inflammatory bowel disease.
Autorzy:: Bhosle A; Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Harvard Chan Microbiome in Public Health Center, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Bae S; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Zhang Y; Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Harvard Chan Microbiome in Public Health Center, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Chun E; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Avila-Pacheco J; Metabolomics Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Geistlinger L; Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York, New York, NY, USA.; Center for Computational Biomedicine, Harvard Medical School, Boston, MA, USA.
Pishchany G; Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Glickman JN; Beth Israel Deaconess Medical Center, Boston, MA, USA.; Department of Pathology, Harvard Medical School, Boston, MA, USA.
Michaud M; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Waldron L; Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York, New York, NY, USA.
Clish CB; Metabolomics Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Xavier RJ; Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Gastrointestinal Unit and Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology, Cambridge, MA, USA.
Vlamakis H; Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Franzosa EA; Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Harvard Chan Microbiome in Public Health Center, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Garrett WS; Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Chan Microbiome in Public Health Center, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Huttenhower C; Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. .; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA. .; Harvard Chan Microbiome in Public Health Center, Harvard T. H. Chan School of Public Health, Boston, MA, USA. .; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA. .; Pokaż więcej
Źródło:: Molecular systems biology [Mol Syst Biol] 2024 Apr; Vol. 20 (4), pp. 338-361. Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:: Journal Article
MeSH Terms:: Inflammatory Bowel Diseases*/drug therapy
Inflammatory Bowel Diseases*/metabolism
Colitis*
Humans ; Animals ; Mice ; Metabolome ; Bile Acids and Salts

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Estrogen receptor activation remodels TEAD1 gene expression to alleviate hepatic steatosis.
Autorzy:: Sommerauer C; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institute, Science for Life Laboratory, Solna, Sweden.
Gallardo-Dodd CJ; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institute, Science for Life Laboratory, Solna, Sweden.
Savva C; Department of Medicine, Integrated Cardio Metabolic Center, Karolinska Institute, Huddinge, Sweden.
Hases L; Department of Protein Science, KTH Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden.; Department of Biosciences and Nutrition, Karolinska Institute, Huddinge, Sweden.
Birgersson M; Department of Protein Science, KTH Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden.; Department of Biosciences and Nutrition, Karolinska Institute, Huddinge, Sweden.
Indukuri R; Department of Protein Science, KTH Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden.; Department of Biosciences and Nutrition, Karolinska Institute, Huddinge, Sweden.
Shen JX; Department of Physiology and Pharmacology, Karolinska Institute, Solna, Sweden.
Carravilla P; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institute, Science for Life Laboratory, Solna, Sweden.; Department of Women's and Children's Health, Karolinska Institute, Science for Life Laboratory, Solna, Sweden.
Geng K; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institute, Science for Life Laboratory, Solna, Sweden.
Nørskov Søndergaard J; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institute, Science for Life Laboratory, Solna, Sweden.
Ferrer-Aumatell C; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institute, Science for Life Laboratory, Solna, Sweden.
Mercier G; Department of Physiology and Pharmacology, Karolinska Institute, Solna, Sweden.
Sezgin E; Department of Women's and Children's Health, Karolinska Institute, Science for Life Laboratory, Solna, Sweden.
Korach-André M; Department of Medicine, Integrated Cardio Metabolic Center, Karolinska Institute, Huddinge, Sweden.
Petersson C; Department of Drug Metabolism and Pharmacokinetics, The Healthcare Business of Merck KGaA, Darmstadt, Germany.
Hagström H; Department of Medicine Huddinge, Karolinska Institute, Huddinge, Sweden.; Division of Hepatology, Department of Upper GI Diseases, Karolinska University Hospital Huddinge, Huddinge, Sweden.
Lauschke VM; Department of Physiology and Pharmacology, Karolinska Institute, Solna, Sweden.; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tübingen, Tübingen, Germany.
Archer A; Department of Protein Science, KTH Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden.; Department of Biosciences and Nutrition, Karolinska Institute, Huddinge, Sweden.
Williams C; Department of Protein Science, KTH Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden.; Department of Biosciences and Nutrition, Karolinska Institute, Huddinge, Sweden.
Kutter C; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institute, Science for Life Laboratory, Solna, Sweden. .; Pokaż więcej
Źródło:: Molecular systems biology [Mol Syst Biol] 2024 Apr; Vol. 20 (4), pp. 374-402. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:: Journal Article
MeSH Terms:: Fatty Liver*/genetics
Fatty Liver*/metabolism
Non-alcoholic Fatty Liver Disease*/genetics
Non-alcoholic Fatty Liver Disease*/metabolism
Animals ; Female ; Humans ; Male ; Mice ; Diet, High-Fat/adverse effects ; Estrogens ; Gene Expression ; Liver/metabolism ; Mice, Inbred C57BL ; Receptors, Estrogen/genetics ; Receptors, Estrogen/metabolism ; Receptors, Estrogen/therapeutic use ; TEA Domain Transcription Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition.
Autorzy:: Burtscher ML; Heidelberg University, Faculty of Medicine, Heidelberg University Hospital, Institute for Computational Biomedicine, Heidelberg, Germany.; Cellzome, a GSK company, Heidelberg, Germany.; Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
Gade S; Cellzome, a GSK company, Heidelberg, Germany.
Garrido-Rodriguez M; Heidelberg University, Faculty of Medicine, Heidelberg University Hospital, Institute for Computational Biomedicine, Heidelberg, Germany.; Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
Rutkowska A; Cellzome, a GSK company, Heidelberg, Germany.
Werner T; Cellzome, a GSK company, Heidelberg, Germany.
Eberl HC; Cellzome, a GSK company, Heidelberg, Germany.
Petretich M; Cellzome, a GSK company, Heidelberg, Germany.
Knopf N; Cellzome, a GSK company, Heidelberg, Germany.
Zirngibl K; Heidelberg University, Faculty of Medicine, Heidelberg University Hospital, Institute for Computational Biomedicine, Heidelberg, Germany.; Cellzome, a GSK company, Heidelberg, Germany.
Grandi P; Cellzome, a GSK company, Heidelberg, Germany.
Bergamini G; Cellzome, a GSK company, Heidelberg, Germany.
Bantscheff M; Cellzome, a GSK company, Heidelberg, Germany.
Fälth-Savitski M; Cellzome, a GSK company, Heidelberg, Germany. .
Saez-Rodriguez J; Heidelberg University, Faculty of Medicine, Heidelberg University Hospital, Institute for Computational Biomedicine, Heidelberg, Germany. .; Pokaż więcej
Źródło:: Molecular systems biology [Mol Syst Biol] 2024 Apr; Vol. 20 (4), pp. 458-474. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:: Journal Article
MeSH Terms:: Proteome*
Poly(ADP-ribose) Polymerase Inhibitors*/pharmacology
Multiomics ; Poly(ADP-ribose) Polymerases/genetics ; Poly(ADP-ribose) Polymerases/metabolism ; Proteomics/methods

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""London"" wg kryterium: PB

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji